ALMAPHARMA
Board
1 director, no change since 2022Director, permanent representative
appointed by deed of 26-04-2022
term without a fixed end
also on the board of 2 other companies
listed in the 2025 annual accounts, filed on 07-04-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 15: Externe vertegenwoordigingsbevoegdheid. De vennootschap wordt vertegenwoordigd jegens derden, met inbegrip van de…”deed of 22-04-2024
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayDirector
Director
BoardEarlier
Mandates as a list
-
- Director, appointed by deed of 26-04-2022, still in office
-
- Director, from 12-09-1985 to 30-03-2022
Control
Subscribers
,
This company
ALMAPHARMA
Equity €256,263
Profit €28,272 in 2025
Capital
- Contribution
- €20,000
- Shares
- 310
- Contribution per share
- €64.52
- Equity per share
- €827 in 2025
- Source
- 2025 annual accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 22-04-2024 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 10 June at 10:00deed of 22-04-2024 (in Dutch)
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Beslissing tot ontbinding, besluit algemene vergadering volgens regels in 24 statuten”deed of 10-01-2014 (in Dutch)
Shareholders
After the capital increase
deed of 10-01-2014 ↗
- €139,494.19
- €905.81
Capital transactions
Capital over time
- 22-04-2024 Capital stated in the deed · 310 shares
- 09-01-2018 Capital increase of €140,400 · to €217,246.99
- 09-01-2018 Capital reduction of €140,400 · to €76,846.99 · repaid to the shareholders
- 09-01-2018 Capital reduction of €56,846.99 · to €20,000 · repaid to the shareholders
- 10-01-2014 Capital increase of €140,400 · to €217,246.99 · no new shares · in kind